Suplatast tosylate side) Nitrobenzylthioinosine (NBMPR) binding sites in

Nitrobenzylthioinosine (NBMPR) binding sites in kidney

small molecules similar to TCS PIM-1 1 may serve as useful starting scaffolds for the development of other improved yet selective Pim-1 inhibitors

BX-795 displays higher growth inhibition with IC50 of 0

P5091 was administered through IV injection at 10 mg/kg twice weekly for 3 weeks

Proteomics

Suplatast tosylate side) Nitrobenzylthioinosine (NBMPR) binding sites inSuplatast tosylate, also known as Suplatast tosilate, is a Th2 cytokine inhibitor which is used as an antiallergic drug. Often used in the treatment of Kimura's disease. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T cells mediated IL 9 gene expression in toluene 2, 4 diisocyanate sensitized rats. uplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3